Tuesday, October 03, 2017

Patriot One (TSX.V: $PAT.V) (OTCQB: $PTOTF) Receives #FCC Approval for PATSCAN CMR; World-class Solution for Global Threat Detection

"We now hold both FCC and Industry Canada (IC) certification" - CTO Dinesh Kandanchatha

Patriot One's (TSX.V: $PAT.V) (OTCQB: $PTOTF) on Investorideas.com

TORONTO, ON - October 3, 2017 (Investorideas.com Newswire) Patriot One Technologies Inc., (TSX.V: PAT) (OTCQB: PTOTF) (FRANKFURT: 0PL) announces that its award-winning PATSCAN CMR™ (Cognitive Microwave Radar) concealed weapons detection system has achieved Federal Communications Commission (FCC) Declaration of Conformity certification, a copy of which can be found here: https://fccid.io/2ALZTCMR.
"This is a momentous occasion for us," states Patriot One Technologies CTO Dinesh Kandanchatha. "We now hold both FCC and Industry Canada (IC) certification allowing us to move into commercial roll-out across North America, with other countries soon to follow. The next stage of this exciting journey now begins with select deployments with key early adopters. Our system, which relies on machine learning algorithms, has graduated from the lab and is about to enter the arena of commercial distribution. Our strategy involves deployment through the remainder of the year to meet our backlog of commitments, and to immerse our engineering teams into an in-depth analysis of real-world threat scenarios in order to ensure that Patriot One offers the leading world-class solution for global threat detection.
"This is an important milestone for the Patriot One team for which they should be proud," said Governor Tom Ridge, first U.S. Secretary of Homeland Security and a member of the Patriot One Advisory Board. "I very much look forward to seeing the rollout of this game-changing technology across the United States and to supporting their efforts to improve public safety."
"We have used the waiting period for regulatory approval to assemble a team capable of meeting the go-to market challenges ahead." Kandanchatha continues, "I anticipate a phased rollout, and like any new technology we will advance carefully and deliberately, recognizing progress will come quickly as we learn from each installation. We have worked hard to ensure that our system would pass this rigorous hurdle and to have achieved it in less than a year is a testament to our team of dedicated engineers, researchers and support staff who have put in the huge effort to achieve today's news."
PATSCAN CMR sales efforts currently focus on markets encompassing houses of worship, academic institutions, event centres, casinos, commercial offices, hotel properties, government agencies and other locations at high risk of terrorist attack or random violence. Interest and orders have been received from around the globe and today's announcement will trigger a number of sales, marketing and support initiatives in major markets including the United Kingdom, Eurozone and Asia-Pacific regions.
"This is wonderful news for our company, our stakeholders and shareholders alike." states Company CEO Martin Cronin. "We well understand that there are hurdles with any new technology, especially when it is revolutionary. We are also very clear regarding the role that the investment community has played in getting us to where we are today, and we will redouble our commitment as we move ahead to build shareholder value and to earn capital market support. Today we celebrate meeting a significant building block in our strategy for public safety through threat detection and our ongoing mission to make the world a safer place."
ON BEHALF OF THE BOARD
"Martin Cronin"
CEO & Director
About Patriot One Technologies, Inc. (TSX.V:PAT) (OTCQB: PTOTF) (FRA: 0PL):
Patriot One has developed PATSCAN CMR™ the next generation of its award-winning radar device and software solution. PATSCAN CMR is a first-of-its-kind Cognitive Microwave Radar concealed weapons detection system, designed as an effective tool to combat active shooter threats before they occur. Built for cost-effective deployment in weapon-restricted buildings and facilities, the Patriot One software solution and related hardware can be installed in hallways and doorways to covertly identify weapons and to alert security of an active threat entering the premises. Owner/operators of private and certain public facilities can now prominently post anti-weapons policies with compliance assured. The Company's motto Deter, Detect and Defend is based on the belief that widespread use of its technology will act as an effective deterrent, thereby diminishing the epidemic phenomena of active shooters across the globe. For more information, visit: www.patriot1tech.com. Patriot One Technologies are proud winners of the 2017 Anti-Terrorism / Force Protection category of the Security Industry Association's New Product Showcase at ISC West.
For further information, please contact:
Patriot One Inquiries
+1 (888) 728-1832
info@patriot1tech.com
www.patriot1tech.com
CAUTIONARY DISCLAIMER STATEMENT:
No Securities Exchange has reviewed nor accepts responsibility for the adequacy or accuracy of the content of this news release. This news release contains forward-looking statements relating to product development, licensing, commercialization and regulatory compliance issues and other statements that are not historical facts. Forward-looking statements are often identified by terms such as "will", "may", "should", "anticipate", "expects" and similar expressions. All statements other than statements of historical fact, included in this release are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from the Company's expectations include the failure to satisfy the conditions of the relevant securities exchange(s) and other risks detailed from time to time in the filings made by the Company with securities regulations. The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Company. The reader is cautioned not to place undue reliance on any forward-looking information. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made as of the date of this news release and the Company will update or revise publicly any of the included forward-looking statements as expressly required by applicable law.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
This news is published on the Investorideas.com Newswire – News that Inspires big ideas Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp. Disclosure this news is a paid for news release on the Investorideas.com newswire by Patriot One Technologies Inc., (TSX.V: PAT) (OTCQB: PTOTF) Learn more about costs and our newswire service http://www.investorideas.com/News-Upload/
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

HomelandDefenseStocks.com - investing ideas for Defense stocks, Biometrics stocks, Homeland security stocks, Biodefense stocks, Cyber security stocks

Like Defense and Security Stocks? View our Defense and Security Stocks Directory

Get News Alerts on Defense Stocks

#Crowdfunding News: Gopher Protocol (OTCQB: $GOPH) Retains Large Media to Manage its Guardian Pet Tracker Indiegogo campaign


ATLANTA, GA - October 3, 2017 (Investorideas.com Newswire) Crowdfunding News - Gopher Protocol Inc. (OTCQB: GOPH) , a development-stage company which specializes in the creation of Internet of Things (IoT), Artificial Intelligence enabled mobile technologies and distribution, engages Large Media to launch the Guardian Orb Indiegogo and marketing campaign. As announced on August 28, 2017, the Company launched a Beta Awareness Campaign for The GUARDIAN ORB Proprietary Pet Tracking Device on the Indiegogo platform at https://www.indiegogo.com/projects/guardian-orb-the-most-advanced-gps-pet-tracker-dog/coming_soon. Large Media will take over the beta campaign as well as the related conversion to an actual campaign.
Gopher's engagement with Large Media followed several months of due diligence and interviews. Gopher Protocol was introduced to Large Media through Indiegogo. The Company is also in negotiation with Indiegogo on the terms of a strategic campaign agreement, which in essence, if executed and if qualified will provide for promotions by Indiegogo of the Company's campaign.
Large Media's Partner and COO, Audrey Binkowski, will be heading up the team. "As dog fanatics and experienced crowdfunding marketers, teaming up with GOPHER Protocol to launch the Guardian Orb's Indiegogo campaign was a natural fit. We recognize that in an ideal world, no pet would ever slip out the back door and run off or get stolen from someone's yard. But, we also understand that no matter how cautious pet owners are, sometimes the unthinkable happens. The peace of mind that comes from knowing your best friend will come home is something you can't put a price on. We are thrilled to be able to bring this invaluable device to pet parents everywhere," said Audrey.
About Large Media
Large Media is a thriving, Catskill Mountains-based marketing firm that utilizes a data-driven approach combined with creative thinking to deliver social and digital marketing programs that deliver real ROI. Large Media's client experience includes working with leading Fortune 500 companies, small- to mid-size businesses and the hottest startups including Tile, Coin, Navdy, Vessyl and more. Large Media's work-from-home agency model offers its clients greater attention to detail, insights backed by data and critical thinking. Large Media was founded in 2009.
About Indiegogo
Indiegogo is an international crowdfunding website founded in 2008 by Danae Ringelmann,[2] Slava Rubin, and Eric Schell. Its headquarters are in San Francisco, California. The site is one of the first sites to offer crowd funding. Indiegogo allows people to solicit funds for an idea, charity, or start-up business. Indiegogo charges a 5% fee on contributions. This charge is in addition to credit card and PayPal charges that range from 3.5% to 9%. Fifteen million people visit the site each month.
The site runs on a rewards-based system, meaning donors, investors, or customers who are willing help to fund a project or product can donate and receive a gift, rather than an equity stake in the company. Following changes in Security and Exchange Commission rules earlier in 2016, Indiegogo has partnered with MicroVentures to offer equity-based campaigns beginning in November 2016, allowing unaccredited investors to participate with equity stakes.
About Gopher Protocol Inc.
Gopher Protocol Inc. (OTCQB: GOPH) ("Gopher" and the "Company") (http://gopherprotocol.com/) is a development-stage company which considers itself Native IoT creator, developing Internet of Things (IoT), Artificial Intelligence enabled mobile technology, and distribution company. The Company has a portfolio of Intellectual Property that when commercialized will include smart microchips, mobile application software and supporting cloud software and an infrastructure that includes approximately 15,000 "store within a store" locations that distributes cellular and financial services products along with UGO branded products. The system contemplates the creation of a global network. The core of the system will be its advanced microchip technology that can be installed in any mobile device worldwide. Gopher envisions this system as an internal, private network between all enabled mobile devices providing shared processing, advanced mobile database management/sharing and enhanced mobile features.
Corporate Site: http://gopherprotocol.com
Press page/ press kit - http://gopherprotocol.com/?page_id=228
Consumer and product website for Guardian Patch: http://www.guardianpatch.com/.
About Guardian Pet Tracker www.guardianpettracker.com
The Guardian Pet Tracker (Sphere Internal name - the "Sphere") system is a derivative technology of Gopher's Guardian Patch technology. The Sphere is designed to provide its users with local tracking capability using a re-chargeable/replaceable battery source. Gopher intends to release pre-production units in limited test in the near future.
GOPH disclosure: More info: SEC link /technology abstract:
Forward-Looking Statements
Certain statements contained in this press release may constitute "forward-looking statements." Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors as disclosed in our filings with the Securities and Exchange Commission located at their website (http://www.sec.gov). In addition to these factors, actual future performance, outcomes, and results may differ materially because of more general factors including (without limitation) general industry and market conditions and growth rates, economic conditions, and governmental and public policy changes. The forward-looking statements included in this press release represent the Company's views as of the date of this press release and these views could change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing the Company's views as of any date subsequent to the date of the press release.
Contact:
Greg Bauer CEO
Gopher Protocol Inc.
VM Only 888-685-7336
Media: press@gopherprotocol.com

Gopher Protocol, Inc. (OTCQB:GOPH) is a featured tech stock on Investorideas.com

Visit profile page
Get News Alerts on Gopher Protocol, Inc.

Disclaimer/Disclosure:
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Disclosure: GOPH is a PR , social media and publishing client and compensates Investorideas.com (effective April 4, 2016 - three thousand five hundred per month )More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

TechSectorStocks.com - investing ideas in tech stocks- mobile payments, social media, AI and Robotics, Drone Stocks, GPS, Internet of Things (IoT)

Like Tech Stocks? View our Tech Stocks Directory

#Tech News: NXT-ID (NASDAQ: $NXTD) COO and Fit Pay President, Michael Orlando to be a Featured Speaker at Secure Technology Alliance's IoT Payments 2017 Conference

Industry event for financial executives, device providers and retail industry executives to examine the evolving intersection of payments and IoT

Investorideas.com - NXT-ID Inc. (NASDAQ: NXTD)

MELBOURNE, Florida - October 3, 2017 (Investorideas.com Newswire) Michael Orlando, COO of NXT-ID, Inc. (NASDAQ:NXTD) and president of Fit Pay, Inc. will be a Plenary Featured Speaker at the IoT Payments 2017, an industry event hosted by the Secure Technology Alliance that explores the evolving world of Internet of Things (IoT) payments.
IoT Payments 2017, which takes place October 10-11, 2017 at the Hyatt Regency in Austin, Texas, will bring together experts from both the IoT and payments communities to discuss the most important developments, innovations and efforts driving secure, seamless IoT payments. The event is organized by the Secure Technology Alliance (formerly the Smart Card Alliance), a not-for-profit, multi-industry association working to stimulate the understanding, adoption and widespread application of secure solutions, including smart cards, embedded chip technology, and related hardware and software. Orlando's featured presentation, entitled 'Connected Commerce: The Internet of Payments', will cover IoT payments business models, use cases and adoption trends.
Orlando is COO of NXT-ID and president of Fit Pay, Inc. With 22 years of payment industry experience, he has held leadership positions in several successful companies, including Cybersource, where he played a primary role in its $2B acquisition by Visa. In 2014, Orlando Co-founded Fit Pay, which provides an end-to-end contactless payment solution for IoT devices. In May 2017, Fit Pay combined businesses with NXT-ID, and is now a wholly-owned subsidiary of the IoT and security technology company.
The FitPay Payment PlatformTM is a proprietary technology platform that delivers payment, credential management, authentication and other secure services to the IoT ecosystem. The platform uses tokenization, a payment security technology that replaces cardholders' account information with a unique digital identifier (a "token"), to transact highly secure contactless payment and authentication services. FitPay leverages Embedded Secure Element (eSE) chip technology within devices to offer a payment solution that is very power and memory efficient and does not need to refresh a token once it is issued. This frees devices from needing to be tethered to a host device or connected to the Internet to transact payments, creating a superior user experience. FitPay's end-to-end payment solution allows IoT and wearable device manufacturers to add payment and authentication capabilities to their products with very little start-up time, no investment in software development and access to the leading credit card networks.
About NXT-ID Inc.
Nxt-ID, Inc. (NASDAQ:NXTD) provides a comprehensive platform of technology products and services that enable the Internet of Things (IoT). With extensive experience in access control, biometric and behavior-metric identity verification, security and privacy, encryption and data protection, payments, miniaturization and sensor technologies, NXT-ID develops and markets groundbreaking solutions for payment and IoT applications. Its industry-leading technology products and solutions include MobileBio®, a suite of biometric solutions that secure consumers' mobile platforms, the Wocket™, a next-generation smart wallet and the Flye, a digital credit card developed in collaboration with WorldVentures.
NXT-ID includes three mobile and IoT-related subsidiaries: LogicMark, LLC, a manufacturer and distributor of non-monitored and monitored personal emergency response systems ("PERS") sold through dealers/distributors and the United States Department of Veterans Affairs; Fit Pay, Inc., a proprietary technology platform that delivers end-to-end solutions to device manufacturers for contactless payment capabilities, credential management, authentication and other secure services within the IoT ecosystem, and 3D-ID LLC, which is engaged in biometric identification and authentication. Learn more about NXT-ID at http://nxt-id.com/. FitPay and the FitPay Payment Platform are the sole property of Fit Pay, Inc.
Forward-Looking Statements for NXT-ID: This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements reflect management's current expectations, as of the date of this press release, and involve certain risks and uncertainties. Forward-looking statements include statements herein with respect to the successful execution of the Company's business strategy. The Company's actual results could differ materially from those anticipated in these forward-looking statements as a result of various factors. Such risks and uncertainties include, among other things, our ability to establish and maintain the proprietary nature of our technology through the patent process, as well as our ability to possibly license from others patents and patent applications necessary to develop products; the availability of financing; the Company's ability to implement its long range business plan for various applications of its technology; the Company's ability to enter into agreements with any necessary marketing and/or distribution partners; the impact of competition, the obtaining and maintenance of any necessary regulatory clearances applicable to applications of the Company's technology; and management of growth and other risks and uncertainties that may be detailed from time to time in the Company's reports filed with the Securities and Exchange Commission.
NXT- ID Inc Contact:
Corporate info: info@nxt-id.com
Media:
Chris Orlando
chris.orlando@nxt-id.com
D. Van Zant
+1-800-665-0411
press@nxt-id.com

NXT-ID, Inc. (NASDAQ:NXTD)

is a Featured tech company on Investorideas.com
Visit Profile page: http://www.investorideas.com/CO/NXT/
Get News Alerts on NXT-ID, Inc.
Investorideas.com Newswire
This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders
Disclaimer/Disclosure:
Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp. Disclosure: Nxt-ID, Inc. (NXTD) is a long term paid news publication and PR client of Investorideas.com. Renewed October 1, 2016 - see details at http://www.investorideas.com/About/News/Clientspecifics.asp

Monday, October 02, 2017

#Tech News: Gopher Protocol (OTCQB: $GOPH) Engages Large Media to Manage its Guardian Orb Indiegogo campaign

Gopher Protocol Inc. (OTC:GOPH)

ATLANTA, GA - October 2, 2017 (Investorideas.com Newswire) Gopher Protocol Inc. (OTCQB: GOPH) ("Gopher" or the "Company"), a development-stage company which specializes in the creation of Internet of Things (IoT), Artificial Intelligence enabled mobile technologies and distribution, engages Large Media to launch the Guardian Orb Indiegogo and marketing campaign. As announced on August 28, 2017, the Company launched a Beta Awareness Campaign for The GUARDIAN ORB Proprietary Pet Tracking Device on the Indiegogo platform at https://www.indiegogo.com/projects/guardian-orb-the-most-advanced-gps-pet-tracker-dog/coming_soon. Large Media will take over the beta campaign as well as the related conversion to an actual campaign.
Gopher's engagement with Large Media followed several months of due diligence and interviews. Gopher Protocol was introduced to Large Media through Indiegogo. The Company is also in negotiation with Indiegogo on the terms of a strategic campaign agreement, which in essence, if executed and if qualified will provide for promotions by Indiegogo of the Company's campaign.
Large Media's Partner and COO, Audrey Binkowski, will be heading up the team. "As dog fanatics and experienced crowdfunding marketers, teaming up with GOPHER Protocol to launch the Guardian Orb's Indiegogo campaign was a natural fit. We recognize that in an ideal world, no pet would ever slip out the back door and run off or get stolen from someone's yard. But, we also understand that no matter how cautious pet owners are, sometimes the unthinkable happens. The peace of mind that comes from knowing your best friend will come home is something you can't put a price on. We are thrilled to be able to bring this invaluable device to pet parents everywhere," said Audrey.
About Large Media
Large Media is a thriving, Catskill Mountains-based marketing firm that utilizes a data-driven approach combined with creative thinking to deliver social and digital marketing programs that deliver real ROI. Large Media's client experience includes working with leading Fortune 500 companies, small- to mid-size businesses and the hottest startups including Tile, Coin, Navdy, Vessyl and more. Large Media's work-from-home agency model offers its clients greater attention to detail, insights backed by data and critical thinking. Large Media was founded in 2009.
About Indiegogo
Indiegogo is an international crowdfunding website founded in 2008 by Danae Ringelmann,[2] Slava Rubin, and Eric Schell. Its headquarters are in San Francisco, California. The site is one of the first sites to offer crowd funding. Indiegogo allows people to solicit funds for an idea, charity, or start-up business. Indiegogo charges a 5% fee on contributions. This charge is in addition to credit card and PayPal charges that range from 3.5% to 9%. Fifteen million people visit the site each month.
The site runs on a rewards-based system, meaning donors, investors, or customers who are willing help to fund a project or product can donate and receive a gift, rather than an equity stake in the company. Following changes in Security and Exchange Commission rules earlier in 2016, Indiegogo has partnered with MicroVentures to offer equity-based campaigns beginning in November 2016, allowing unaccredited investors to participate with equity stakes.
About Gopher Protocol Inc.
Gopher Protocol Inc. (OTCQB: GOPH) ("Gopher" and the "Company") (http://gopherprotocol.com/) is a development-stage company which considers itself Native IoT creator, developing Internet of Things (IoT), Artificial Intelligence enabled mobile technology, and distribution company. The Company has a portfolio of Intellectual Property that when commercialized will include smart microchips, mobile application software and supporting cloud software and an infrastructure that includes approximately 15,000 "store within a store" locations that distributes cellular and financial services products along with UGO branded products. The system contemplates the creation of a global network. The core of the system will be its advanced microchip technology that can be installed in any mobile device worldwide. Gopher envisions this system as an internal, private network between all enabled mobile devices providing shared processing, advanced mobile database management/sharing and enhanced mobile features.
Corporate Site: http://gopherprotocol.com
Press page/ press kit - http://gopherprotocol.com/?page_id=228
Consumer and product website for Guardian Patch: http://www.guardianpatch.com/.
About Guardian Pet Tracker www.guardianpettracker.com
The Guardian Pet Tracker (Sphere Internal name - the "Sphere") system is a derivative technology of Gopher's Guardian Patch technology. The Sphere is designed to provide its users with local tracking capability using a re-chargeable/replaceable battery source. Gopher intends to release pre-production units in limited test in the near future.
GOPH disclosure: More info: SEC link /technology abstract:
Forward-Looking Statements
Certain statements contained in this press release may constitute "forward-looking statements." Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors as disclosed in our filings with the Securities and Exchange Commission located at their website (http://www.sec.gov). In addition to these factors, actual future performance, outcomes, and results may differ materially because of more general factors including (without limitation) general industry and market conditions and growth rates, economic conditions, and governmental and public policy changes. The forward-looking statements included in this press release represent the Company's views as of the date of this press release and these views could change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing the Company's views as of any date subsequent to the date of the press release.
Contact:
Greg Bauer CEO
Gopher Protocol Inc.
VM Only 888-685-7336
Media: press@gopherprotocol.com

Gopher Protocol, Inc. (OTCQB:GOPH) is a featured tech stock on Investorideas.com

Visit profile page
Get News Alerts on Gopher Protocol, Inc.

Disclaimer/Disclosure:
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Disclosure: GOPH is a PR , social media and publishing client and compensates Investorideas.com (effective April 4, 2016 - three thousand five hundred per month )More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

TechSectorStocks.com - investing ideas in tech stocks- mobile payments, social media, AI and Robotics, Drone Stocks, GPS, Internet of Things (IoT)

Like Tech Stocks? View our Tech Stocks Directory

Patriot One (TSX.V: $PAT.V) (OTCQB: $PTOTF) Receives #FCC Approval for PATSCAN CMR Paving Way for Commercial Roll-Out; @patriot1tech

Major Milestone Achieved in Less than a Year by Concealed Weapons Detection System Developer

Patriot One's (TSX.V: $PAT.V) (OTCQB: $PTOTF) on Investorideas.com

TORONTO, ON - October 2, 2017 (Investorideas.com Newswire) Patriot One Technologies Inc., (TSX.V: PAT) (OTCQB: PTOTF) (FRANKFURT: 0PL) ("Patriot One" or the "Company"), is extremely pleased to announce that its award-winning PATSCAN CMR™ (Cognitive Microwave Radar) concealed weapons detection system has achieved Federal Communications Commission (FCC) Declaration of Conformity certification, a copy of which can be found here: https://fccid.io/2ALZTCMR.
"This is a momentous occasion for us," states Patriot One Technologies CTO Dinesh Kandanchatha. "We now hold both FCC and Industry Canada (IC) certification allowing us to move into commercial roll-out across North America, with other countries soon to follow. The next stage of this exciting journey now begins with select deployments with key early adopters. Our system, which relies on machine learning algorithms, has graduated from the lab and is about to enter the arena of commercial distribution. Our strategy involves deployment through the remainder of the year to meet our backlog of commitments, and to immerse our engineering teams into an in-depth analysis of real-world threat scenarios in order to ensure that Patriot One offers the leading world-class solution for global threat detection.
"This is an important milestone for the Patriot One team for which they should be proud," said Governor Tom Ridge, first U.S. Secretary of Homeland Security and a member of the Patriot One Advisory Board. "I very much look forward to seeing the rollout of this game-changing technology across the United States and to supporting their efforts to improve public safety."
"We have used the waiting period for regulatory approval to assemble a team capable of meeting the go-to market challenges ahead." Kandanchatha continues, "I anticipate a phased rollout, and like any new technology we will advance carefully and deliberately, recognizing progress will come quickly as we learn from each installation. We have worked hard to ensure that our system would pass this rigorous hurdle and to have achieved it in less than a year is a testament to our team of dedicated engineers, researchers and support staff who have put in the huge effort to achieve today's news."
PATSCAN CMR sales efforts currently focus on markets encompassing houses of worship, academic institutions, event centres, casinos, commercial offices, hotel properties, government agencies and other locations at high risk of terrorist attack or random violence. Interest and orders have been received from around the globe and today's announcement will trigger a number of sales, marketing and support initiatives in major markets including the United Kingdom, Eurozone and Asia-Pacific regions.
"This is wonderful news for our company, our stakeholders and shareholders alike." states Company CEO Martin Cronin. "We well understand that there are hurdles with any new technology, especially when it is revolutionary. We are also very clear regarding the role that the investment community has played in getting us to where we are today, and we will redouble our commitment as we move ahead to build shareholder value and to earn capital market support. Today we celebrate meeting a significant building block in our strategy for public safety through threat detection and our ongoing mission to make the world a safer place."
ON BEHALF OF THE BOARD
"Martin Cronin"
CEO & Director
About Patriot One Technologies, Inc. (TSX.V:PAT) (OTCQB: PTOTF) (FRA: 0PL):
Patriot One has developed PATSCAN CMR™ the next generation of its award-winning radar device and software solution. PATSCAN CMR is a first-of-its-kind Cognitive Microwave Radar concealed weapons detection system, designed as an effective tool to combat active shooter threats before they occur. Built for cost-effective deployment in weapon-restricted buildings and facilities, the Patriot One software solution and related hardware can be installed in hallways and doorways to covertly identify weapons and to alert security of an active threat entering the premises. Owner/operators of private and certain public facilities can now prominently post anti-weapons policies with compliance assured. The Company's motto Deter, Detect and Defend is based on the belief that widespread use of its technology will act as an effective deterrent, thereby diminishing the epidemic phenomena of active shooters across the globe. For more information, visit: www.patriot1tech.com. Patriot One Technologies are proud winners of the 2017 Anti-Terrorism / Force Protection category of the Security Industry Association's New Product Showcase at ISC West.
For further information, please contact:
Patriot One Inquiries
+1 (888) 728-1832
info@patriot1tech.com
www.patriot1tech.com
CAUTIONARY DISCLAIMER STATEMENT:
No Securities Exchange has reviewed nor accepts responsibility for the adequacy or accuracy of the content of this news release. This news release contains forward-looking statements relating to product development, licensing, commercialization and regulatory compliance issues and other statements that are not historical facts. Forward-looking statements are often identified by terms such as "will", "may", "should", "anticipate", "expects" and similar expressions. All statements other than statements of historical fact, included in this release are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from the Company's expectations include the failure to satisfy the conditions of the relevant securities exchange(s) and other risks detailed from time to time in the filings made by the Company with securities regulations. The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Company. The reader is cautioned not to place undue reliance on any forward-looking information. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made as of the date of this news release and the Company will update or revise publicly any of the included forward-looking statements as expressly required by applicable law.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
This news is published on the Investorideas.com Newswire – News that Inspires big ideas Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp. Disclosure this news is a paid for news release on the Investorideas.com newswire by Patriot One Technologies Inc., (TSX.V: PAT) (OTCQB: PTOTF) Learn more about costs and our newswire service http://www.investorideas.com/News-Upload/
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

HomelandDefenseStocks.com - investing ideas for Defense stocks, Biometrics stocks, Homeland security stocks, Biodefense stocks, Cyber security stocks

Like Defense and Security Stocks? View our Defense and Security Stocks Directory

Get News Alerts on Defense Stocks

Scythian Biosciences Corp. (TSXV: $SCYB.V) Announces Bart Oates, 5-time #NFL Pro Bowl player and a 3-time Super Bowl Champion Joins Professional Athlete Advisory Committee

Investorideas Featured Company: Scythian Biosciences Corp. (TSX.V: SCYB)

TORONTO - October 2, 2017 (Investorideas.com Newswire) Scythian Biosciences Corp. (the "Company") (TSXV: SCYB) announces the formation of its Professional Athlete Advisory Committee and the first appointment ,with Bart Oates, a 5-time NFL Pro Bowl player and a 3-time Super Bowl Champion joining the new Committee. The purpose of this committee is to bring together various, current, and former pro-athletes who have experienced or share concern for the pain and suffering associated with concussions that occur during sports competitions.
"The member's intimate knowledge and personal experience will lend Scythian and our research partners at the University of Miami great insight into the world of sports and the aftermath of head injuries. Bart Oates, who has been an Advisory Board member will head up this committee and lead in recruiting new inductees from Professional Football, Hockey, Basketball, Boxing, Soccer and more," commented Mr. Jonathan Gilbert, CEO of the Company.
About Mr. Oates
A former center for the New York Giants and San Francisco 49ers, Bart Oates is a 5-time NFL Pro Bowl player and a 3-time Super Bowl Champion. Once finished with football, Mr. Oates took law classes and then worked as an attorney, receiving his law degree from Seton Hall University. Mr. Oates maintains an active role in many services to the community, including serving as President of the NY/NJ Chapter of the NFL Alumni Association.
Stock Options
The Company has also issued 62,500 incentive stock options to an officer and advisors of the Company entitling the grantees to purchase up to 62,500 common shares of the Company at an exercise price of $8.00 per share for a period of five years. The options are subject to certain vesting provisions and are subject to regulatory approval.
About Scythian Biosciences Corp.
Scythian is a research and development company committed to finding a solution for the prevention and treatment of concussions and traumatic brain injury with its proprietary Cannabinoid combination.
Scythian's mission is to be the first accepted drug regimen for concussive treatment. Scythian has recently formed a collaboration with the University of Miami and its world renowned neuroscientific team to conduct pre-clinical and clinical trials of its drug regimen. The University of Miami believes that Scythian's scientific approach shows significant promise and differs from previous approaches to treat this growing problem. The collaboration with the University of Miami allows access to their extensive knowledge base in the fields of traumatic brain injury and concussions and allows for Scythian's clinical studies to be undertaken at their world-class facilities
Gillian A. Hotz, PhD, is leading Scythian's program at the University of Miami. Dr. Hotz is a nationally recognized behavioral neuroscientist and expert in neurotrauma, concussion management, and neurorehabilitation. She has extensive experience in neurocognitive testing. Dr. Hotz has been the co-director of University of Miami Miller School of Medicine's Concussion Program since 1995.
Scythian is also endorsed by Pro Football Legends and the World Boxing Association on its mission.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Forward-Looking Statements
This press release may contain certain forward-looking information and statements ("forward-looking information") within the meaning of applicable Canadian securities legislation, that are not based on historical fact, including without limitation statements containing the words "believes", "anticipates", "plans", "intends", "will", "should", "expects", "continue", "estimate", "forecasts" and other similar expressions. Readers are cautioned to not place undue reliance on forward-looking information. Actual results and developments may differ materially from those contemplated by these statements. The Company undertakes no obligation to comment on analyses, expectations or statements made by third-parties in respect of the Company, its securities, or financial or operating results (as applicable). Although the Company believes that the expectations reflected in forward-looking information in this press release are reasonable, such forward-looking information has been based on expectations, factors and assumptions concerning future events which may prove to be inaccurate and are subject to numerous risks and uncertainties, certain of which are beyond the Company's control, including the risk factors discussed in the Filing Statement and the registration statement which are incorporated herein by reference and are available through SEDAR at www.sedar.com and on the SEC EDGAR filing service at www.sec.gov. The forward-looking information contained in this press release are expressly qualified by this cautionary statement and are made as of the date hereof. The Company disclaims any intention and has no obligation or responsibility, except as required by law, to update or revise any forward-looking information, whether as a result of new information, future events or otherwise.
For further information, please contact:
Scythian Biosciences Corp.
Jonathan Gilbert
CEO
Phone: (212) 729-9208
Email: info@scythianbio.com

Scythian Biosciences Corp. (TSX.V: SCYB)

is a Featured biotech and marijuana company on Investorideas.com
Visit Profile page: http://www.investorideas.com/CO/SCYB/
Get News Alerts on Scythian Biosciences Corp.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.
Scythian Biosciences Corp. (SCYB) is a paid featured company on the 420 Cannabis Investor Ideas Directory and is a paid featured cannabis company and biotech for news, social media and PR effective August 7th for 2 months. More details - http://www.investorideas.com/About/News/Clientspecifics.asp
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

Thursday, September 28, 2017

Scythian Biosciences Corp. (TSXV: $SCYB.V) Forms Professional Athlete Advisory Committee

www.investorideas.com - News that inspires big Ideas

TORONTO - September 28, 2017 (Investorideas.com Newswire) Scythian Biosciences Corp. (the "Company") (TSXV: SCYB) is pleased to announce the formation of its Professional Athlete Advisory Committee. The purpose of this committee is to bring together various, current, and former pro-athletes who have experienced or share concern for the pain and suffering associated with concussions that occur during sports competitions.
"The member's intimate knowledge and personal experience will lend Scythian and our research partners at the University of Miami great insight into the world of sports and the aftermath of head injuries. Bart Oates, who has been an Advisory Board member will head up this committee and lead in recruiting new inductees from Professional Football, Hockey, Basketball, Boxing, Soccer and more," commented Mr. Jonathan Gilbert, CEO of the Company.

http://www.investorideas.com/CO/SCYB/news/2017/09281ProfessionalAthlete.asp

Tuesday, September 26, 2017

SinglePoint (OTC: $SING) Finalizes Letter of Intent to Acquire 51% of Denver-Based Company approaching $1 Million in Annual Revenue

www.investorideas.com - News that inspires big Ideas

SEATTLE, WA - September 26, 2017 (Investorideas.com Newswire) SinglePoint, Inc. (OTC:SING), a holding company specialized in the acquisition of small to mid-sized companies with an emphasis on new technologies, today announces that it has signed a Letter of Intent ("LOI") to acquire a Denver, Colorado-based company that is approaching $1 million in annual revenue. According to the LOI, SinglePoint will acquire 51 percent of the acquisition target in a stock and cash transaction expected to increase shareholder and company value, and deliver to SinglePoint immediate revenues with a healthy margin.
Year-to-date SinglePoint has acquired or invested in three companies resulting in revenue growth and solidifying the Company's revenue-by-acquisition model. This agreement is yet another demonstration of SinglePoint's ability to strategically grow its portfolio of investments in established, high-potential companies.
SinglePoint CEO Greg Lambrecht states, "We are committed to identifying and making investments in companies that strengthen SinglePoint's value. Our goal is to find and acquire companies we believe will add instant value as well as the opportunity for major growth."
SinglePoint plans to close this opportunity within the coming weeks. The company has additional acquisition targets that are in negotiation and will continue to pursue revenue-generating companies that are in alignment with SinglePoint's goals.
In addition to this LOI, SinglePoint is nearing its completion of 2016 audited financials. Upon completion SinglePoint will apply to up-list to the OTCQB. Management expects to have this audit completed in 2018


Disclosure: SinglePoint, Inc. (OTC: $SING) is featured on the 420 Cannabis Investor Ideas of 2017 at www.420cannabisinvestorideas.com
SinglePoint, Inc. (OTC: SING) is a featured company on Investorideas.com
View the profile on Investorideas.com

Disclaimer: This directory is not a recommendation to buy or sell securities or products or services Investorideas.com charges a fee for placement. The directory is not an endorsement or recommendation but meant to be an investor resource/ due diligence tool.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp. Disclosure: Companies Featured on the 420 Cannabis Investor Ideas have paid a one-time fee of Up to $1000 to be featured on the directory and SING is also a paid featured cannabis and bitcoin company for news and PR social media
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

http://www.investorideas.com/CO/SING/news/2017/09261Acquire.asp


Monday, September 25, 2017

Pershing Gold (NASDAQ: $PGLC) (TSX: $PGLC.TO) to Present at 2017 Denver Gold Forum

Pershing Gold (NASDAQ: $PGLC) (TSX: $PGLC.TO) to Present at 2017 Denver Gold Forum



LAKEWOOD, Colo. - September 25, 2017 (Investorideas.com Newswire) Pershing Gold Corporation (NASDAQ:PGLC) (TSX:PGLC) (FWB:7PG1) ("Pershing Gold" or the "Company"), an emerging Nevada gold producer, announces that Stephen Alfers ("Alfers"), Pershing Gold's Executive Chairman, CEO and President, will present at the 2017 Denver Gold Forum in Colorado Springs, Colorado.
The Denver Gold Forum is being held September 25-27, 2017, at the Broadmoor in Colorado Springs, CO. Alfers will be presenting at 1:45pm on Tuesday, September 26.
Alfers will provide a Company update during the live presentation and participate in one-on-one meetings with registered conference investors. Registration is by invitation only to qualified investors, portfolio managers, and private wealth managers.
A webcast of the presentation will be available on September 29, 2017:
http://www.denvergoldforum.org/xpl17/company-webcast/PGLC:US/
About Pershing Gold Corporation
Pershing Gold is an emerging gold producer whose primary asset is the Relief Canyon Mine in Pershing County, Nevada. Relief Canyon includes three historic open-pit mines and a state-of-the-art, fully permitted and constructed heap-leach processing facility. Pershing Gold is currently permitted to resume mining at Relief Canyon under the existing Plan of Operations.
Pershing Gold's landholdings cover approximately 25,000 acres that include the Relief Canyon Mine asset and lands surrounding the mine in all directions. This land package provides Pershing Gold with the opportunity to expand the Relief Canyon Mine deposit and to explore and make new discoveries on nearby lands.
Pershing Gold is listed on the NASDAQ Global Market and the Toronto Stock Exchange under the symbol PGLC and on the Frankfurt Stock Exchange under the symbol 7PG1.
View original content with multimedia:http://www.prnewswire.com/news-releases/pershing-gold-to-present-at-2017-denver-gold-forum-300525183.html
SOURCE: Pershing Gold Corporation
View original content with multimedia: http://www.newswire.ca/en/releases/archive/September2017/18/c4883.html
Contact Information
For more information, please contact:
Stephen Alfers, Executive Chairman, President and CEO
Jack Perkins, Vice President, Investor Relations
720.974.7254
investors@pershinggold.com
www.PershingGold.com

Pershing Gold Corporation (NASDAQ: PGLC) (TSX:PGLC)

is a Featured mining company on Investorideas.com
Visit Profile page: http://www.investorideas.com/CO/PGLC/
Get News Alerts on Pershing Gold Corporation
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp Disclosure: Pershing Gold Corporation (NASDAQ: PGLC) (TSX: PGLC) is a paid PR, media and news client effective June 2017 for 2 months

Gold Mining Stocks - Gold Mining Stocks Directory, Gold Stocks News, Research and Resources

Gold-MiningStocks.com - investing ideas in gold and mining stocks

Like Gold Stocks? View our Gold / Mining Stocks Directory

Get News on Mining Stocks

#Tech News: Gopher (OTCQB: $GOPH) Proudly Introduces its New CEO

#Tech News: Gopher (OTCQB: $GOPH) Proudly Introduces its New CEO

Gopher Protocol Inc. (OTC:GOPH)

SAN DIEGO, CA - September 25, 2017 (Investorideas.com Newswire) Gopher Protocol Inc. (OTCQB: GOPH) ("Gopher" or the "Company"), a development-stage company which specializes in the creation of Internet of Things (IoT), Artificial Intelligence enabled mobile technologies and distribution is proud to introduce its new CEO to shareholders and followers, in a personal letter from Gregory Bauer:
I wanted to take this opportunity to introduce myself as the new CEO of Gopher Protocol, as well as a fellow shareholder.
I have joined Gopher Protocol as part of Gopher's recent acquisition of UGO HUB assets.
We are going to be using the UGO HUB assets to create a "store within a store" offering several prepaid and cellular services as well as launching our branded UGO accessory product line for consumers. The assets we acquired provide us with basic infrastructure within 15,000 convenience stores located across the United States with a "heavy presence" in the south east to empower a Gopher network for future product releases.
Before we go into the strategy of the acquisition -- I will describe the parts of my background and experience that I believe will help me to succeed as CEO of Gopher Protocol.
My background includes working in technology and product distribution companies. Most recently growing a distribution division to over $140 million in revenue. In addition, I have had previous successful exits selling companies to large corporations and in the technology information space. I also have experience running public companies, so I am familiar with the requirements.
Based on my experience, I am excited about the opportunities I see in Gopher Protocol to expand the existing technology and take it to market. Let me start by describing the current operations of the assets recently acquired.
The recent Gopher acquisition will be generating revenues as a retail partner of the major telecoms through the distribution of financial products as well as cellular "top-off" cards. We believe this acquisition is a game changer for Gopher with the goal of placing Gopher on the path to a cash flow positive company. In addition, our goal is to provide the Company with more flexibility in developing and deploying its technology portfolio and to take advantage of the disruptive products developed by our CTO Danny Rittman.
Allowing that the acquisition makes sense from a financial standpoint, the beauty of having 15,000 points of presence across the United States will allow us to distribute our internal inventions in those locations, in the future.
Finally, and perhaps most importantly, it is our goal to deploy connected devices into those locations to create the radio frequency network that we described in our recent video -- https://youtu.be/9ovYCMHmOi8. This will create the access points to the internet needed by our connected devices which will allow them to connect to the internet with no monthly fees.
To summarize our recent moves:
New CEO with public company experience, investor exits, and building large companies.
15,000 distribution points for our soon to be launched products with access to an estimated 30,000,000* customers weekly. (*http://distributech.net//Demographics.aspx)
I look forward to building shareholder value as we execute on the ambitious plans we have for the future.
Best regards,
Gregory Bauer
About UGO HUB
UGO HUB products include: prepaid financial services (credit card, phone card, gift card, etc.), financial services - bill pay, ATM, payday loans, check cashing, Bitcoin, etc.), products and accessories - SIM Card, cell phone, as well as novelties, such as electronic accessories. UGO HUB operates on a leased space and revenue sharing arrangement with partner locations instead of a traditional wholesaling model.
About Gopher Protocol Inc.
Gopher Protocol Inc. (OTCQB: GOPH) ("Gopher" and the "Company") (http://gopherprotocol.com/) is a development-stage company which consider itself Native IoT creator, developing Internet of Things (IoT) and Artificial Intelligence enabled mobile technology. The Company has a portfolio of Intellectual Property that when commercialized will include smart microchips, mobile application software and supporting cloud software. The system contemplates the creation of a global network. The core of the system will be its advanced microchip technology that can be installed in any mobile device worldwide. Gopher envisions this system as an internal, private network between all enabled mobile devices providing shared processing, advanced mobile database management/sharing and enhanced mobile features.
Corporate Site: http://gopherprotocol.com
Press page/ press kit - http://gopherprotocol.com/?page_id=228
Consumer and product website for Guardian Patch: http://www.guardianpatch.com/.
About Guardian Pet Tracker www.guardianpettracker.com
The Guardian Pet Tracker (Sphere Internal name -- the "Sphere") system is a derivative technology of Gopher's Guardian Patch technology. The Sphere is designed to provide its users with local tracking capability using a re-chargeable/replaceable battery source. Gopher intends to release pre-production units in limited test in the near future.
GOPH disclosure: More info: SEC link /technology abstract:
Forward-Looking Statements
Certain statements contained in this press release may constitute "forward-looking statements". Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors as disclosed in our filings with the Securities and Exchange Commission located at their website (http://www.sec.gov). In addition to these factors, actual future performance, outcomes, and results may differ materially because of more general factors including (without limitation) general industry and market conditions and growth rates, economic conditions, and governmental and public policy changes. The forward-looking statements included in this press release represent the Company's views as of the date of this press release and these views could change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing the Company's views as of any date subsequent to the date of the press release.
Contact:
Greg Bauer CEO
Gopher Protocol Inc.
VM Only 888-685-7336
Media: press@gopherprotocol.com

Gopher Protocol, Inc. (OTCQB:GOPH) is a featured tech stock on Investorideas.com

Visit profile page
Get News Alerts on Gopher Protocol, Inc.

Disclaimer/Disclosure:
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Disclosure: GOPH is a PR , social media and publishing client and compensates Investorideas.com (effective April 4, 2016 - three thousand five hundred per month )More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

CTO of Scythian Biosciences Corp. (TSXV: $SCYB.V) Talks about Drug Development and Commercialization and Potential of #Cannabinoids

CTO of Scythian Biosciences Corp. (TSXV: $SCYB.V) Talks about Drug Development and Commercialization and Potential of #Cannabinoids

Former VP of Celgene (NASDAQ: $CELG) Talks about Scythian’s Potential Treatment for Concussion and/or TBI

September 25, 2017 – Investorideas.com, a global news source and investor resource covering cannabis and biotech stocks releases an exclusive Q&A  interview with  Maghsoud Dariani, CTO of Scythian Biosciences Corp. (TSXV: SCYB).

Scythian Biosciences Corp. (TSXV: SCYB) reported September 13th that Maghsoud Dariani has become the Chief Scientific Officer of the Company. Mr. Dariani was previously on the Company's advisory board and has over 35 years of experience in the development and commercialization of products in the pharmaceutical industry. Mr. Dariani's experience includes, among other things, management positions at Semorex, Focus Pharmaceuticals, Celgene (NASDAQ: CELG) and Chiral Pharmaceuticals.

Q&A Interview:

Q: Investorideas.com
Congratulations on your recent appointment as Chief Scientific Officer of Scythian Biosciences. Can you talk about your new role and based on the current stage of development of the company’s drug treatment for concussions and traumatic brain injury with its proprietary Cannabinoid combination, what you see as the next steps?

A: Maghsoud Dariani, Chief Scientific Officer
Thank you! I am excited to join Scythian Biosciences and look forward to working with the team to manage the development of our proprietary Cannabinoid combination drug for the treatment of concussion and traumatic brain injury (TBI).  We are extremely fortunate to be collaborating with the University of Miami, a premier research center on concussion and TBI to develop an effective drug treatment for this disorder. TBI, which can result in long-term negative and life altering symptoms affects more than 2 million; mostly young people in the US alone and there is no standard drug treatment, making this a significant unmet need. 

We are currently conducting pre-clinical studies in accepted rodent models to establish the efficacy of our combination drug for TBI and to determine effective dosing.  Upon completion of this stage, we will embark on IND enabling studies, Toxicology, Pharmacokinetics, Pharmacodynamics, ADME (absorption, distribution, metabolism, and excretion), and CMC (chemistry, manufacturing, and control).  We are working with a premier FDA consulting company who will ensure that our pre-clinical and IND enabling studies are in line with FDA requirements and will assist us in preparing our IND package for submission to the FDA.  Upon FDA acceptance of our IND, we will initiate our human clinical trials in collaboration with the University of Miami and possibly other TBI centers of excellence.

Q: Investorideas.com
Can you talk about your 35 years of experience in development and commercialization of products in the pharmaceutical industry?

 A: Maghsoud Dariani, Chief Scientific Officer

Excellent question.  What I have learned during my drug development and commercialization journey is that success requires i) being meticulous and completely thorough during pre-clinical evaluation of drugs under development and ii) paying attention to what the data is telling you during early stages of clinical trials.  Pre-clinical pharmacodynamics is relatively inexpensive and can save a lot of money by preventing the wrong compounds from going forward.  The compounds should be evaluated in as many validated models as possible to ensure both efficacy and safety.  Rushing through this stage and cutting corners can result in costly future failures. Once the compounds have successfully passed through pre-clinical development, careful attention to and thorough analyses of the outcomes from phase I and II clinical trials are critical.  Often, companies and people are under pressure to move compounds to phase III pivotal trials, which are very costly and time consuming.  Failure to do adequate early analyses and ignoring what the data is saying results in disappointing and very costly failures in meeting phase III clinical end points.

Q: Investorideas.com
Do you see  taking a different path or strategy for a smaller  company like Scythian Biosciences  versus  working with a larger company like Celgene Corporation  (NASDAQ: CELG) ?


A: Maghsoud Dariani, Chief Scientific Officer
Fundamentally speaking, NO.  Drug development has distinct stages which have to be followed whether you are a small company or a large one.  The only differences that I see, is that smaller companies are much less bureaucratic and there are a lot less layers.  This simply translates to faster decisions and a somewhat shorter timeline to commercialization.

Q: Investorideas.com
Can you talk about what is unique about the company’s drug (s) in development?

A: Maghsoud Dariani, Chief Scientific Officer

There is currently no approved drug for mild traumatic brain injury and concussion which afflicts more than 2 million mostly young people in the US.  Trauma causes inflammation followed by immune response (gliosis) that can damage nerve cells.  Depending on the severity of the trauma, the resulting symptoms can last for several months or stay with injured people for the rest of their lives. Early and successful drug intervention to reduce inflammation and reduce gliosis is urgently needed.  Our drug under development is a combination of two compounds that attack neuronal inflammation and gliosis through two different pathways.  This is a unique and proprietary approach that has not been tried before.   

Q: Investorideas.com
How do you see Cannabinoids playing a role in the future of pharma and biotech?

A: Maghsoud Dariani, Chief Scientific Officer

The cannabinoid system is present throughout the central nervous system and is crucial for controlling a range neurophysiological processes such as pain, appetite, learning and memory.  The cannabinoid receptors, CB1 and CB2 in the central nervous system are also targets for cannabinoids isolated from the cannabis plant (marijuana) as well as their synthetic analogues. The cannabinoid system has emerged as a key regulator of neuronal cell fate and is seen as capable of conferring neuroprotection.  Many neurological diseases have neurodegenerative components that result from neuroinflammation, oxidative stress and excitotoxicity.  Natural and synthetic cannabinoids represent a class of compounds that are attractive for the development of neurodegenerative diseases such as epilepsy, Tourette’s syndrome, multiple sclerosis, pain, schizophrenia, Alzheimer's disease and cerebral ischemia.

Q: Investorideas.com
In closing on a personal note, what motivated and inspired you to come on board as Chief Scientific Officer of Scythian?

A: Maghsoud Dariani, Chief Scientific Officer

I love challenges and developing a potential treatment for concussion and/or mild traumatic brain injury is a big challenge!  It is a condition with unmet need that afflicts significant number of people.  I also have an excellent track record in overseeing and managing R&D, and when Jonathan asked me to join his team, it was a great fit and I accepted it with enthusiasm.

About Mr. Dariani

Mr. Dariani has over 35 years of diverse and progressive management experience in the development and commercialization of products in the pharmaceutical industry. Mr. Dariani has a successful record of business management, strategic planning, acquisition and divestiture, project management, production management, R&D management, economic evaluations, competitor analyses, and development and administration of multi-million dollar budgets. Mr. Dariani is an entrepreneurial business leader with a sound grasp of successful business strategies, an excellent foundation in science and engineering, and a strong background in product development and commercialization. He is currently the CEO of Semorex Inc. – a privately held company focused on the discovery and development of novel therapeutics for cancer. Mr. Dariani also leads Myos Rens' science and technology efforts and has overall responsibilities for manufacturing, basic science, pre-clinical and clinical studies. Prior to joining Semorex Inc., Mr. Dariani was President of Focus Pharmaceuticals, Inc ("Focus") where he managed the development and approval of drug products, achieving one FDA approval and bringing another to the clinical evaluation stage. Prior to joining Focus, Mr. Dariani was Vice President of the chiral pharmaceutical business unit at Celgene Corporation ("Celgene"). During his twelve years at Celgene, Mr. Dariani developed and implemented Celgene's manufacturing strategy, managed and successfully sold Celgene's chiral intermediates business unit, and formulated a strategic plan for leveraging Celgene's expertise in chiral technologies towards the development of chirally pure drug products. Mr. Dariani was responsible for the successful development and FDA approval of the chirally pure versions of Ritalin, which are currently marketed by Novartis under the Focalin and Focalin XR trade names. Prior to Celgene, Mr. Dariani held progressively more responsible engineering and development positions at Celanese Corporation. Mr. Dariani holds a Bachelor of Science from The City College of New York and a Master of Science from University of Massachusetts in Chemical Engineering. Mr. Dariani is a member of Board of Directors at Semorex Inc. and Mesa Therapeutics.

Description:
Maghsoud Dariani, Chief Scientific Officer Scythian Biosciences Corp. (TSXV: SCYB)

Scythian is a research and development company committed to finding a solution for the prevention and treatment of concussions and traumatic brain injury with its proprietary Cannabinoid combination.

Scythian's mission is to be the first accepted drug regimen for concussive treatment. Scythian has recently formed a collaboration with the University of Miami and its world renowned neuroscientific team to conduct pre-clinical and clinical trials of its drug regimen. The University of Miami believes that Scythian's scientific approach shows significant promise and differs from previous approaches to treat this growing problem. The collaboration with the University of Miami allows access to their extensive knowledge base in the fields of traumatic brain injury and concussions and allows for Scythian's clinical studies to be undertaken at their world-class facilities

Gillian A. Hotz, PhD, is leading Scythian's program at the University of Miami. Dr. Hotz is a nationally recognized behavioral neuroscientist and expert in neurotrauma, concussion management, and neurorehabilitation. She has extensive experience in neurocognitive testing. Dr. Hotz has been the co-director of University of Miami Miller School of Medicine's Concussion Program since 1995.

Scythian is also endorsed by Pro Football Legends and the World Boxing Association on its mission.

Subscribe to our cannabis news RSS feed: http://www.investorideas.com/rss/feeds/portals/marijuana.xml

For a full list of marijuana and cannabis stocks visit:

About Investorideas.com - News that Inspires Big Ideas
Investorideas.com is a meeting place for global investors, featuring news, stock directories, video, company profiles, interviews and more in leading sectors.   Investorideas.com cannabis/marijuana and hemp content now includes http://cannabisstocknews.blogspot.com on Blogger.com: the Investorideas.com news and stock directory pages, a cannabis investor group on Linkedin.com, The 420 Cannabis Investor ideas www.420cannabisinvestorideas.com and the new AI site  Global Cannabis Investing at www.Globalcannabisinvesting.com.


Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.
Scythian Biosciences Corp. (SCYB) is a paid featured company on the 420 Cannabis Investor Ideas Directory and is a paid featured Cannabis Company and biotech for news, social media and PR effective August 7th for 2 months. More details - http://www.investorideas.com/About/News/Clientspecifics.asp

Visit the Scythian Biosciences (TSX.V: SCYB) Profile page: http://www.investorideas.com/CO/SCYB/

Contact Investorideas.com

800-665-0411